Image by Viacheslav Iakobchuk - Adobe Stock
Illumina has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the United States and the United Kingdom.
Unlocking the power of the human genome is a feat that no one organization can fully accomplish on its own. That's why, back in 2014, Illumina created the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry.
Now in its sixth year, the Illumina Accelerator has just selected nine new genomics companies to join its latest funding cycle — four companies for the accelerator's Cambridge, England location, and five companies for the San Francisco Bay Area location. The Illumina Accelerator has helped create a total of 54 genomics companies including the nine that were just announced.